- Previous
- Next
30 May 2026
Red Then Dead
B cells - major members of the immune system – can become cancerous (B-cell leukaemias or lymphomas) or malfunction (such as in autoimmune diseases like lupus or rheumatoid arthritis) and treatments can include targeting them for destruction by binding them with an antibody marker specific to them. Often not efficient, this B-cell removal approach has been improved by presenting the binding antibody on red blood cells (in green here) that mark the offending cells (fluorescing red here) with a loud and clear 'eat me' tag
Read the published research article here
Written by
- Image from work by Jiaqi Liu, Fengju Wang and Lian Li
- Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, West China School of Pharmacy, Sichuan University, Chengdu, China
- Image originally published with a Creative Commons Attribution 4.0 International (CC BY 4.0)
- Published in Sciences Advances, May 2026
Search The Archive
Submit An Image
Like us on Facebook
Follow on Twitter
Follow on Tumblr
Follow on Instagram
What is BPoD?
BPoD stands for Biomedical Picture of the Day. Managed by the MRC Laboratory of Medical Sciences until Jul 2023, it is now run independently by a dedicated team of scientists and writers. The website aims to engage everyone, young and old, in the wonders of biology, and its influence on medicine. The ever-growing archive of more than 4000 research images documents over a decade of progress. Explore the collection and see what you discover. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.